Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma
Open Access
- 23 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 12 (6) , 912-919
Abstract
Living donor liver transplantation (LDLT) has evolved to represent an important surgical strategy for patients with hepatocellular carcinoma (HCC). However, due to disadvantages, including donor risks and higher rates of perioperative complications, LDLT has been considered as a second-line treatment in Japan. The present study retrospectively evaluated clinical outcomes for 93 patients with HCC who underwent LDLT at our institute, including 44 patients who exceeded Milan criteria (MC). A total of 73 patients (78%) displayed a history of previous treatment for HCC using various nontransplant methods. Median follow-up was 24 months (range, 1–76 months). At 4 years after LDLT, overall patient survival rate was 64%, with similar rates for within-MC and over-MC groups (68% vs. 59%, respectively; P = 0.6548). However, cumulative recurrence rate was significantly higher in the over-MC group than in the within-MC group (35% vs. 15%, P = 0.0190). Regarding history of conventional treatment for HCC before LDLT, patients who had received only 1–2 previous treatments showed significantly lower recurrence rates than patients with ≥3 treatments (9% vs. 37%, P = 0.0411). In conclusion, LDLT may constitute an optional treatment with a chance of cure for patients with otherwise uncontrolled disease. However, repeated nontransplant treatments for recurrent HCC prior to LDLT may increase the risk of recurrence and impair the survival advantages conferred by LDLT. Liver Transpl 12:912–919, 2006. © 2006 AASLD.Keywords
This publication has 28 references indexed in Scilit:
- Liver transplantation for hepatocellular carcinomaGastroenterology, 2004
- High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantationLiver Transplantation, 2004
- Resection prior to liver transplantation for hepatocellular carcinoma: A strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver functionLiver Transplantation, 2004
- Transcatheter Arterial Chemotherapy with and without Embolization in Patients with Hepatocellular CarcinomaOncology, 2004
- Comparison of Clinicopathologic Characteristics and Outcomes After Resection in Patients With Hepatocellular Carcinoma Treated in the United States, France, and JapanAnnals of Surgery, 2003
- Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on CirrhosisAnnals of Surgery, 2003
- Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 2001
- Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular CarcinomaAnnals of Surgery, 1998
- The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot studyHepatology, 1997
- Role of Liver Transplantation in Cancer TherapyAnnals of Surgery, 1985